Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment

1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment

US Patent 8969355 · Granted Mar 3, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-pro2025
Catecholamine prodrugs for use in the treatment of Parkinson's disease2025
Formulations/compositions comprising ibrutinib2025
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-prop2024
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
1-[2-(2,4-dimeihylphenylsulfanyl)-phenyl]piperazine as a compound with combined 2022
Vortioxetine pyroglutamate2022
Vortioxetine pyroglutamate2022
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-prop2021
Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperaz2020
Phenyl-piperazine derivatives as serotonin reuptake inhibitors2020
Vortioxetine pyroglutamate2019